Category: St. Jude MedicalSyndicate content

CEO says SNN 'working hard' on acquisitions trail | The week in medtech M&A

May 6, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Smith & Nephew 'working hard' on acquisitions trail, CEO says; Profound Medical goes public in reverse merger; Greatbatch mulls spinout for Algostim SCS business; Wright Medical delays Augment timeline; St. Jude Medical closes Spinal Modulation buy

Smith & Nephew 'working hard' on acquisitions trail, CEO says

April 30, 2015 by Brad Perriello

FDA approves STJ's MRI-safe SCS device | Regulatory news for the week of May 4, 2015

May 5, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA approves MRI-safe SCS device from St. Jude Medical; Surprise CE Mark for Stentys Xposition S stent; Wright Medical delays Augment timeline; FTC: We might force M&A divestitures in outside markets; FDA closes out CryoLife warning letter, PerClot trial launches

FDA approves MRI-safe SCS device from St. Jude Medical

April 30, 2015 by Brad Perriello

St. Jude Medical closes Spinal Modulation buy

May 4, 2015 by Brad Perriello

St. Jude Medical closes its $175 million buyout of Spinal Modulation as it expands its footprint in the neuromodulation space.

St. Jude Medical closes Spinal Modulation buy

FDA approves MRI-safe SCS device from St. Jude Medical

April 30, 2015 by Brad Perriello

The FDA approves St. Jude Medical's Protégé MRI spinal cord stimulation device for head and extremity MRI scans.

FDA approves MRI-safe SCS device from St. Jude Medical

St. Jude Medical's Q1 beats own guidance and Wall Street's

April 22, 2015 by Brad Perriello

St. Jude Medical's 1st-quarter earnings top both its own guidance and Wall Street's outlook, prompting the medical device company to boost its 2015 sales forecast.

St. Jude Medical's Q1 beats own guidance and Wall Street's

St. Jude Medical pulls the trigger on Spinal Modulation buy

April 20, 2015 by Brad Perriello

St. Jude Medical says it exercised the buyout option on its deal with Spinal Modulation and its Axium chronic pain device.

St. Jude Medical pulls the trigger on Spinal Modulation buy

CRM: BSX's gain is STJ's loss | Medtech Wall Street news for the week of March 23, 2015

March 26, 2015 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific's gain is St. Jude Medical's loss; Abiomed soars to new all-time high on FDA nod; Philips mulls 2016 IPO for lighting biz as bidding war heats up; SteadyMed prices $40m IPO well under range; Becton Dickinson to shed assets after CareFusion buy

CRM: Boston Scientific's gain is St. Jude Medical's loss

March 20, 2015 by Brad Perriello